The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties

Wed, 07th Jul 2021 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

UBS RAISES NATWEST PRICE TARGET TO 214 (205) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES NATWEST PRICE TARGET TO 315 (310) PENCE - 'CONVICTION BUY LIST'

----------

GOLDMAN SACHS RAISES HSBC PRICE TARGET TO 600 (585) PENCE - 'BUY'

----------

UBS CUTS STANDARD CHARTERED PRICE TARGET TO 490 (530) PENCE - 'NEUTRAL'

----------

UBS RAISES LLOYDS PRICE TARGET TO 54 (51) PENCE - 'BUY'

----------

UBS RAISES BARCLAYS PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES ASTRAZENECA PRICE TARGET TO 6,950 (6,800) PENCE - 'SELL'

----------

GOLDMAN SACHS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,870 (1,800) PENCE - 'BUY'

----------

BARCLAYS RAISES J SAINSBURY PRICE TARGET TO 305 (285) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES J SAINSBURY PRICE TARGET TO 295 (280) PENCE - 'HOLD'

----------

UBS RAISES SAINSBURY PRICE TARGET TO 300 (290) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 256 (228) PENCE - 'OUTPERFORM'

----------

JPMORGAN RAISES SEGRO PRICE TARGET TO 1,195 (1,075) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES CRODA INTERNATIONAL PRICE TARGET TO 7,100 (6,400) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES AVEVA GROUP PRICE TARGET TO 4,300 (4,000) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

BERENBERG INITIATES SHAFTESBURY WITH 'BUY' - TARGET 725 PENCE

----------

BERENBERG INITIATES CAPITAL & COUNTIES WITH 'BUY' - TARGET 200 PENCE

----------

BERENBERG CUTS MORRISON SUPERMARKETS TO 'HOLD' ('BUY') - TARGET 254 (202) PENCE

----------

JEFFERIES RESUMES IG GROUP WITH 'BUY' - TARGET 1050 PENCE

----------

PEEL HUNT RAISES REDROW PRICE TARGET TO 830 (750) PENCE - 'BUY'

----------

UBS RAISES CREST NICHOLSON PRICE TARGET TO 380 (330) PENCE - 'SELL'

----------

MORGAN STANLEY RAISES CENTRICA PRICE TARGET TO 58 (55) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES ASTON MARTIN PRICE TARGET TO 1,430 (1,200) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES ASTON MARTIN PRICE TARGET TO 1,988 (1,966) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES VIRGIN MONEY PRICE TARGET TO 215 (210) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

BANK OF AMERICA CUTS ASOS TO 'NEUTRAL' (BUY) - PRICE TARGET 5,500 (6,500) PENCE

----------

PEEL HUNT RAISES TEN ENTERTAINMENT PRICE TARGET TO 325 (300) PENCE - 'BUY'

----------

PEEL HUNT RAISES ADVANCED MEDICAL SOLUTIONS PRICE TARGET TO 280 (228) P - HOLD

----------

PEEL HUNT RAISES ACCESSO TECHNOLOGY TO 'BUY' ('ADD') - TARGET 699 (678) PENCE

----------

CREDIT SUISSE RAISES SENIOR PRICE TARGET TO 200 (125) PENCE - 'OUTPERFORM'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 935 (950) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES ALLIED IRISH BANKS PRICE TARGET TO 3,25 (3,15) EUR - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.